文献速递血液净化与透析

频繁血液透析网络每日试验中增加透析频率和时间对尿毒症溶质浓度的有限降低

Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
PubMed 文献 · Kidney Int · 2017-01-12

本研究比较频繁血液透析网络每日试验中53例每周三次、平均每周10.9小时血液透析患者与30例每周六次、平均14.6小时血液透析患者储存样本的尿毒症溶质浓度。代谢组学分析显示增加治疗频率和时间仅使107种尿毒症溶质水平平均降低15%,定量检测证实对假想尿毒症毒素硫酸对甲酚和硫酸吲哚酚无显著降低。动力学模型提示增加透析频率和时长降低溶质浓度的能力可能受非透析性溶质清除和/或溶质产生变化限制。

要点

  • 增加透析频率和时间仅使107种尿毒症溶质水平平均降低15%
  • 增加治疗未显著降低硫酸对甲酚或硫酸吲哚酚水平
  • 非透析性溶质清除和/或溶质产生变化可能限制溶质浓度降低

核心结论

  • 增加血液透析频率和每周治疗时间未能大幅降低尿毒症溶质浓度,这可能部分解释频繁血液透析网络每日试验中观察到的有限获益。

研究设计与样本

  • 比较频繁血液透析网络每日试验中53例每周三次中心血液透析(平均每周10.9小时)与30例每周六次中心血液透析(平均14.6小时)患者储存样本的尿毒症溶质浓度。

主要发现

  • 代谢组学分析显示增加治疗频率和时间使107种尿毒症溶质水平平均降低15%。
  • 定量检测证实增加治疗未显著降低假想尿毒症毒素硫酸对甲酚或硫酸吲哚酚水平。
  • 动力学模型提示增加血液透析频率和时长降低溶质浓度的能力可能受非透析性溶质清除和/或溶质产生变化限制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Frequent Hemodialysis Network Daily Trial compared conventional three-times weekly treatment to more frequent treatment with a longer weekly treatment time in patients receiving in-center hemodialysis. Evaluation at one year showed favorable effects of more intensive treatment on left ventricular mass, blood pressure, and phosphate control, but modest or no effects on physical or cognitive performance. The current study compared plasma concentrations of uremic solutes in stored samples from 53 trial patients who received three-times weekly in-center hemodialysis for an average weekly time of 10.9 hours and 30 trial patients who received six-times weekly in-center hemodialysis for an average of 14.6 hours. Metabolomic analysis revealed that increased treatment frequency and time resulted in an average reduction of only 15 percent in the levels of 107 uremic solutes. Quantitative assays confirmed that increased treatment did not significantly reduce levels of the putative uremic toxins p-cresol sulfate or indoxyl sulfate. Kinetic modeling suggested that our ability to lower solute concentrations by increasing hemodialysis frequency and duration may be limited by the presence of non-dialytic solute clearances and/or changes in solute production. Thus, failure to achieve larger reductions in uremic solute concentrations may account, in part, for the limited benefits observed with increasing frequency and weekly treatment time in Frequent Hemodialysis Daily Trial participants.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Sirich TL, Fong K, Larive B, et al. Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial. Kidney Int. 2017. PMID: 28089366. doi:10.1016/j.kint.2016.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。